scholarly journals Measures of sleep: The Insomnia Severity Index, Medical Outcomes Study (MOS) Sleep Scale, Pittsburgh Sleep Diary (PSD), and Pittsburgh Sleep Quality Index (PSQI)

2003 ◽  
Vol 49 (S5) ◽  
pp. S184-S196 ◽  
Author(s):  
Michael T. Smith ◽  
Stephen T. Wegener
2019 ◽  
Vol 33 (11) ◽  
pp. 1388-1394 ◽  
Author(s):  
Bing Cao ◽  
Caroline Park ◽  
Joshua D Rosenblat ◽  
Yan Chen ◽  
Michelle Iacobucci ◽  
...  

Background Sleep disturbances are frequently reported in patients with major depressive disorder. We aimed to investigate the effects of vortioxetine on sleep quality and association between changes in sleep and treatment response. Methods: This study is a post-hoc analysis of a clinical trial that sought to evaluate the sensitivity to cognitive change of THINC-integrated tool in patients with major depressive disorder. In total, 92 patients (aged 18 to 65) meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for moderate or severe major depressive disorder and 54 healthy controls were included. All patients received open-label vortioxetine (10–20 mg/day, flexibly dosed) for 8 weeks. Herein, the primary outcomes of interest were changes in sleep, as measured by the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale and Insomnia Severity Index, between weeks 0, 2, and 8. The association between changes in sleep and depressive symptom severity was secondarily assessed. Results: We observed that sleep, as indicated by scores of Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale and Insomnia Severity Index, was significantly poorer in patients with major depressive disorder compared to healthy controls at weeks 0, 2, and 8 ( p < 0.05). Among patients with major depressive disorder, we observed significant improvements on the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale and Insomnia Severity Index between weeks 0 and 8 ( p < 0.05). We observed a significant association between improvements on the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and Insomnia Severity Index and improvement of depressive symptoms. Conclusion: Improvement of depressive symptoms in major depressive disorder patients treated with vortioxetine was associated with significant improvements in sleep. Furthermore, improvements in sleep were predictive of antidepressant response and were linearly correlated with improvement in overall depressive symptom severity.


Author(s):  
Samir El Sayed ◽  
Sarah Gomaa ◽  
Doaa Shokry ◽  
Ahmed Kabil ◽  
Ahmed Eissa

Abstract Background COVID-19 pandemic became a global health problem affecting the life of millions of people all over the world. The effects of this pandemic were not only on the physical and medical aspects but also on the psychological issues including anxiety disorders, depressive manifestations, sleep problems and others. Sleep disorders were very commonly reported during the novel Coronavirus-19 pandemic either in the acute phase of COVID-19 infection or after recovery. These sleep problems might have a drastic burden on the recovered patients’ life. This study aimed to investigate the sleep in the post-Coronavirus-19 period and if has an impact on the different items of patients’ quality of life. This cross-sectional observational study investigated the sleep problems in 500 patients in the post recovery period using Insomnia Severity Index and Pittsburgh sleep quality index (PSQI), their relation to this critical period and their impact on different domains of Quality of Life which was assessed by the SF36 Health Survey. Results Socio-demographic characteristics of 500 post-Coronavirus-19 patients were collected; the insomnia severity index and Pittsburgh sleep quality index evaluated the sleep pattern. The quality of life was investigated using Short Form 36 scale. The study revealed high scores of insomnia severity index (13.01 ± 4.9), Pittsburgh sleep quality index (15.37 ± 4.43), also high scores of different items of scale of quality of life in the studied group. Conclusion Post-COVID-19 sleep disturbances were commonly reported in the recovery period, also these sleep deficits had an impact on the physical and mental aspects of quality of life, so these sleep problems must be managed properly especially in this critical pandemic era.


2020 ◽  
Author(s):  
Christian Fadeuilhe Grau ◽  
◽  
Vanesa Richarte Fernández ◽  
Montserrat Corrales de la Cruz ◽  
Raúl Felipe Palma-Álvarez ◽  
...  

Objetivos Identificar la prevalencia y evaluar las características clínicas del insomnio en una muestra de pacientes TDAH adultos con Patología Dual. Material y métodos La muestra la forman 252 pacientes adultos con TDAH remitidos para evaluación diagnóstica al Programa de TDAH del Hospital Universitari Vall d’Hebron. Se realizó una evaluación clínica y psicodiagnóstica, administrándose las escalas SCID-I y SCID-II, CAARS, ADHD Rating Scale y WURS. Igualmente se realizó una evaluación clínica del insomnio complementada con la administración de dos escalas específicas: la Insomnia Severity Index (ISI) y la Pittsburgh Sleep Quality Index (PSQI). Resultados y conclusiones La presencia de insomnio en pacientes adultos con TDAH presentaba una asociación estadísticamente significativa (11.6% vs. 4.3%; p<0.029) en aquellos pacientes que presentaban comórbidamente un Trastorno por uso de sustancias (alcohol, cocaína o cannabis). Esta asociación entre el insomnio y el TDAH adulto también fue identificada en aquellos pacientes adultos con antecedente de Trastorno por uso de sustancias (34.8% vs 15.0%; p<0.0001). Esta asociación era mayor en la presentación combinada del TDAH, observándose igualmente una correlación estadística entre la presencia de insomnio y la severidad clínica del TDAH.


2012 ◽  
Vol 4 (2) ◽  
pp. 202-208 ◽  
Author(s):  
Samantha J. Pulliam ◽  
Debra F. Weinstein ◽  
Atul Malhotra ◽  
Eric A. Macklin ◽  
Lori R. Berkowitz

Abstract Background Work hour limitations for graduate medical trainees, motivated by concerns about patient safety, quality of care, and trainee well-being, continue to generate controversy. Little information about sleep habits and the prevalence of sleep disorders among residents is available to inform policy in this area. Objectives To evaluate the sleep habits of matriculating residents, postgraduate year-1 (PGY-1). Design An anonymous, voluntary, self-administered survey study was used with 3 validated questionnaires: the Pittsburgh Sleep Quality Index, the Insomnia Severity Index, and the Epworth Sleepiness Scale, which were fielded to PGY-1 residents entering the Accreditation Council for Graduate Medical Education–accredited programs at Massachusetts General Hospital and/or Brigham and Women's Hospitals in June and July 2009. Results Of 355 eligible subjects, 310 (87%) participated. Mean sleep time for PGY-1 residents was 7 hours and 34 minutes, and 5.6% of PGY-1 residents had Pittsburgh Sleep Quality Index global scores greater than 5, indicating poor quality sleep. Using multiple linear and ordinal logistic regression models, men had higher Pittsburgh Sleep Quality Index sleep latency scores, whereas women and those with children had higher Epworth Sleepiness Scale daytime sleepiness scores, and 18% of PGY-1 residents had abnormal amounts of daytime sleepiness based on the Epworth Sleepiness Scale. The Insomnia Severity Index identified 4.2% of PGY-1 residents with moderate insomnia. Conclusions Some PGY-1 residents may begin residency with sleep dysfunctions. Efforts to provide targeted help to selected trainees in managing fatigue during residency should be investigated.


Author(s):  
Zubia Veqar ◽  
Mohammed Ejaz Hussain

Abstract Objective: Insomnia severity index (ISI) is a widely used scale in various demographic groups but its psychometric properties have not been established in a sample of Indian subjects. This study was conducted as a preliminary study to extend and confirm the applicability of ISI to an Indian population of university students and to establish its correlation with the Pittsburgh Sleep Quality Index (PSQI). Materials and methods: The study was conducted among the student population of Jamia Millia Islamia, New Delhi, India, with due approval by the institutional ethical committee. Twenty-five poor sleepers with a mean age of 25.24±7.04 years and a BMI of 24.2±2.5 kg/m2 were recruited for the study from the university population. They were administered ISI and PSQI on test day and the same was repeated after 1 week. Results: The test-retest reliability for ISI (intra-class correlation coefficient, ICC2,1−0.84) was excellent. It was further established by the Bland-Altman graph and scatter plot. The results also showed that ISI (Pearson’s coefficient r−0.45) had a strong positive correlation with PSQI. Internal consistency for the ISI (Cronbach’s α–0.84) was excellent. Conclusion: The study findings suggest that ISI has excellent internal consistency, test-retest reliability and validity for the university population of poor sleepers in India. Hence, it can prove to be a good tool for screening insomnia in the current population.


2018 ◽  
Vol 17 (04) ◽  
pp. 459-463 ◽  
Author(s):  
Sriram Yennurajalingam ◽  
Srikanth Reddy Barla ◽  
Joseph Arthur ◽  
Gary B. Chisholm ◽  
Eduardo Bruera

AbstractIntroductionCancer-related drowsiness (CRD) is a distressing symptom in advanced cancer patients (ACP). The aim of this study was to determine the frequency and factors associated with severity of CRD. We also evaluated the screening performance of Edmonton Symptom Assessment Scale-drowsiness (ESAS-D) item against the Epworth Sedation Scale (ESS).MethodWe prospectively assessed 180 consecutive ACP at a tertiary cancer hospital. Patients were surveyed using ESAS, ESS, Pittsburgh Sleep Quality Index, Insomnia Severity Index, and Hospital Anxiety Depression Scale.ResultNinety of 150 evaluable patients had clinically significant CRD (ESS); median (interquartile ratio): ESS. 11 (7–14); ESAS-D. 5 (2–6); Pittsburgh Sleep Quality Index. 8 (5–11); Insomnia Severity Index. 13 (5–19); Stop Bang Scoring 3 (2–4), and Hospital Anxiety Depression Scale-D 6 (3–10). ESAS-D was associated with ESAS (r, p) sleep (0.38, &lt;0.0001); pain (0.3, &lt;0.0001); fatigue (0.51, &lt;0.0001); depression (0.39, &lt;0.0001); anxiety (0.44, &lt;0.0001); shortness of breath (0.32, &lt;0.0001); anorexia (0.36, &lt;0.0001), feeling of well-being [(0.41, &lt;0.0001), ESS (0.24, 0.001), and opioid daily dose (0.19, 0.01). Multivariate-analysis showed ESAS-D was associated with fatigue (odds ratio [OR] = 9.08, p &lt; 0.0001), anxiety (3.0, p = 0.009); feeling of well-being (OR = 2.27, p = 0.04), and insomnia (OR = 2.35; p = 0.036). Insomnia (OR = 2.35; p = 0.036) cutoff score ≥3 (of 10) resulted in a sensitivity of 81% and 32% and specificity of 70% and 44% in the training and validation samples, respectively.Significance of resultsClinically significant CRD is frequent and seen in 50% of ACP. CRD was associated with severity of insomnia, fatigue, anxiety, and worse feeling of well-being. An ESAS-D score of ≥3 is likely to identify most of the ACP with significant CRD.


Sign in / Sign up

Export Citation Format

Share Document